These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 17483111)

  • 1. Complement factor H (Y402H) polymorphism and risk of coronary heart disease in US men and women.
    Pai JK; Manson JE; Rexrode KM; Albert CM; Hunter DJ; Rimm EB
    Eur Heart J; 2007 Jun; 28(11):1297-303. PubMed ID: 17483111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor-gamma2 P12A polymorphism and risk of coronary heart disease in US men and women.
    Pischon T; Pai JK; Manson JE; Hu FB; Rexrode KM; Hunter D; Rimm EB
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1654-8. PubMed ID: 15920035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single nucleotide polymorphisms at the adiponectin locus and risk of coronary heart disease in men and women.
    Pischon T; Pai JK; Manson JE; Hu FB; Rexrode KM; Hunter D; Rimm EB
    Obesity (Silver Spring); 2007 Aug; 15(8):2051-60. PubMed ID: 17712123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The common Y402H variant in complement factor H gene is not associated with susceptibility to myocardial infarction and its related risk factors.
    Stark K; Neureuther K; Sedlacek K; Hengstenberg W; Fischer M; Baessler A; Wiedmann S; Jeron A; Holmer S; Erdmann J; Schunkert H; Hengstenberg C
    Clin Sci (Lond); 2007 Aug; 113(4):213-8. PubMed ID: 17472578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A common polymorphism in the complement factor H gene is associated with increased risk of myocardial infarction: the Rotterdam Study.
    Kardys I; Klaver CC; Despriet DD; Bergen AA; Uitterlinden AG; Hofman A; Oostra BA; Van Duijn CM; de Jong PT; Witteman JC
    J Am Coll Cardiol; 2006 Apr; 47(8):1568-75. PubMed ID: 16630992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lymphotoxin-alpha gene and galectin-2 gene polymorphisms on inflammatory biomarkers, cellular adhesion molecules and risk of coronary heart disease.
    Asselbergs FW; Pai JK; Rexrode KM; Hunter DJ; Rimm EB
    Clin Sci (Lond); 2007 Mar; 112(5):291-8. PubMed ID: 17040205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the nurses' health study.
    Oh K; Hu FB; Manson JE; Stampfer MJ; Willett WC
    Am J Epidemiol; 2005 Apr; 161(7):672-9. PubMed ID: 15781956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement factor H Y402H decreases cardiovascular disease risk in patients with familial hypercholesterolaemia.
    Koeijvoets KC; Mooijaart SP; Dallinga-Thie GM; Defesche JC; Steyerberg EW; Westendorp RG; Kastelein JJ; van Hagen PM; Sijbrands EJ
    Eur Heart J; 2009 Mar; 30(5):618-23. PubMed ID: 19098018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality--results of prospective analysis for the Atherosclerosis Risk in Communities study.
    Hong Y; Jin X; Mo J; Lin HM; Duan Y; Pu M; Wolbrette DL; Liao D
    J Intern Med; 2007 Jul; 262(1):113-22. PubMed ID: 17598819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthy lifestyle factors in the primary prevention of coronary heart disease among men: benefits among users and nonusers of lipid-lowering and antihypertensive medications.
    Chiuve SE; McCullough ML; Sacks FM; Rimm EB
    Circulation; 2006 Jul; 114(2):160-7. PubMed ID: 16818808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty liver and uric acid levels predict incident coronary heart disease but not stroke among atomic bomb survivors in Nagasaki.
    Baba T; Amasaki Y; Soda M; Hida A; Imaizumi M; Ichimaru S; Nakashima E; Seto S; Yano K; Akahoshi M
    Hypertens Res; 2007 Sep; 30(9):823-9. PubMed ID: 18037775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent impact of gout on mortality and risk for coronary heart disease.
    Choi HK; Curhan G
    Circulation; 2007 Aug; 116(8):894-900. PubMed ID: 17698728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene-environment interaction in progression of AMD: the CFH gene, smoking and exposure to chronic infection.
    Baird PN; Robman LD; Richardson AJ; Dimitrov PN; Tikellis G; McCarty CA; Guymer RH
    Hum Mol Genet; 2008 May; 17(9):1299-305. PubMed ID: 18203751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sources of psychosocial disadvantage and risk of coronary heart disease.
    Thurston RC; Kubzansky LD
    Psychosom Med; 2007 Nov; 69(8):748-55. PubMed ID: 17942839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of combining complement factor H and C-reactive protein genetic profiles for predicting myocardial infarction (from the Rotterdam Study).
    Kardys I; de Maat MP; Klaver CC; Despriet DD; Uitterlinden AG; Hofman A; de Jong PT; Witteman JC
    Am J Cardiol; 2007 Aug; 100(4):646-8. PubMed ID: 17697822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma fluorescent oxidation products: independent predictors of coronary heart disease in men.
    Wu T; Rifai N; Willett WC; Rimm EB
    Am J Epidemiol; 2007 Sep; 166(5):544-51. PubMed ID: 17615090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cigarette smoking and risk of coronary heart disease incidence among middle-aged Japanese men and women: the JPHC Study Cohort I.
    Baba S; Iso H; Mannami T; Sasaki S; Okada K; Konishi M; ;
    Eur J Cardiovasc Prev Rehabil; 2006 Apr; 13(2):207-13. PubMed ID: 16575274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement Factor H polymorphism Y402H associates with inflammation, visual acuity, and cardiovascular mortality in the elderly population at large.
    Mooijaart SP; Koeijvoets KM; Sijbrands EJ; Daha MR; Westendorp RG
    Exp Gerontol; 2007 Nov; 42(11):1116-22. PubMed ID: 17869048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement factor H gene polymorphism and risk of cardiovascular disease in end-stage renal disease patients.
    Buraczynska M; Ksiazek P; Zukowski P; Benedyk-Lorens E; Orlowska-Kowalik G
    Clin Immunol; 2009 Aug; 132(2):285-90. PubMed ID: 19428307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lipoprotein lipase gene serine 447 stop variant influences hypertension-induced left ventricular hypertrophy and risk of coronary heart disease.
    Talmud PJ; Flavell DM; Alfakih K; Cooper JA; Balmforth AJ; Sivananthan M; Montgomery HE; Hall AS; Humphries SE
    Clin Sci (Lond); 2007 Jun; 112(12):617-24. PubMed ID: 17291198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.